Ventricular Changes in Patients with Acute COVID-19 Infection: Follow-up of the World Alliance Societies of Echocardiography (WASE-COVID) Study.

Ilya Karagodin, Cristiane Carvalho Singulane, Tine Descamps, Gary M Woodward, Mingxing Xie, Edwin S Tucay, Rizwan Sarwar, Zuilma Y Vasquez-Ortiz, Azin Alizadehasl, Mark J Monaghan, Bayardo A Ordonez Salazar, Laurie Soulat-Dufour, Atoosa Mostafavi, Antonella Moreo, Rodolfo Citro, Akhil Narang, Chun Wu, Karima Addetia, Ana C Tude Rodrigues, Roberto M Lang, Federico M Asch

Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2022;35(3):295-304

PMID: 34752928

Abstract

BACKGROUND

COVID-19 infection is known to cause a wide array of clinical chronic sequelae, but little is known regarding the long-term cardiac complications. We aim to report echocardiographic follow-up findings and describe the changes in left (LV) and right ventricular (RV) function that occur following acute infection.

METHODS

Patients enrolled in the World Alliance Societies of Echocardiography-COVID study with acute COVID-19 infection were asked to return for a follow-up transthoracic echocardiogram. Overall, 198 returned at a mean of 129 days of follow-up, of which 153 had paired baseline and follow-up images that were analyzable, including LV volumes, ejection fraction (LVEF), and longitudinal strain (LVLS). Right-sided echocardiographic parameters included RV global longitudinal strain, RV free wall strain, and RV basal diameter. Paired echocardiographic parameters at baseline and follow-up were compared for the entire cohort and for subgroups based on the baseline LV and RV function.

RESULTS

For the entire cohort, echocardiographic markers of LV and RV function at follow-up were not significantly different from baseline (all P > .05). Patients with hyperdynamic LVEF at baseline (>70%), had a significant reduction of LVEF at follow-up (74.3% ± 3.1% vs 64.4% ± 8.1%, P < .001), while patients with reduced LVEF at baseline (<50%) had a significant increase (42.5% ± 5.9% vs 49.3% ± 13.4%, P = .02), and those with normal LVEF had no change. Patients with normal LVLS (<-18%) at baseline had a significant reduction of LVLS at follow-up (-21.6% ± 2.6% vs -20.3% ± 4.0%, P = .006), while patients with impaired LVLS at baseline had a significant improvement at follow-up (-14.5% ± 2.9% vs -16.7% ± 5.2%, P < .001). Patients with abnormal RV global longitudinal strain (>-20%) at baseline had significant improvement at follow-up (-15.2% ± 3.4% vs -17.4% ± 4.9%, P = .004). Patients with abnormal RV basal diameter (>4.5 cm) at baseline had significant improvement at follow-up (4.9 ± 0.7 cm vs 4.6 ± 0.6 cm, P = .019).

CONCLUSIONS

Overall, there were no significant changes over time in the LV and RV function of patients recovering from COVID-19 infection. However, differences were observed according to baseline LV and RV function, which may reflect recovery from the acute myocardial injury occurring in the acutely ill. Left ventricular and RV function tends to improve in those with impaired baseline function, while it tends to decrease in those with hyperdynamic LV or normal RV function.

Copyright © 2021 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Address: University of Chicago, Chicago, Illinois.; Ultromics, Oxford, United Kingdom.; Union Hospital, Tongji Medical College of HUST, Wuhan, Peoples Republic of China.; Philippine Heart Center, Quezon City, Philippines.; Ultromics, Oxford, United Kingdom; Experimental Therapeutics, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Mexico.; Rajaie Cardiovascular Medical and Research Center, Echocardiography Research Center, IUMS, Tehran, Iran.; King's College Hospital, London, United Kingdom.; Centro Medico Nacional 20 de Noviembre, ISSSTE, Ciudad de Mexico, Mexico.; Saint Antoine and Tenon Hospital, AP-HP, INSERM UMRS-ICAN 1166 and Sorbonne Université, Paris, France.; Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran.; De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.; University of Salerno, Salerno, Italy.; Northwestern University, Chicago, Illinois.; Radiology Institute of the University of Sao Paulo Medical School, São Paulo, Brazil.; MedStar Health Research Institute, Washington, DC. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.